As of 2024-12-12, the Relative Valuation of Talaris Therapeutics Inc (TALS) is (33.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.72 USD, the upside of Talaris Therapeutics Inc based on Relative Valuation is -1326.5%.
The range of the Relative Valuation is (33.92) - (35.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 24.9x | 18.3x |
| Forward P/E multiples | 19.4x - 20.1x | 19.9x |
| Fair Price | (33.92) - (35.18) | (33.36) |
| Upside | -1347.1% - -1393.3% | -1326.5% |
| Date | P/E |